FRED HUTCHINSON CANCER CENTER
Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Conditions
- Myelodysplastic SyndromesLeukemiaMyelodysplastic/Myeloproliferative DiseasesLymphoma
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00062140
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Biological Therapy in Treating Patients With Metastatic Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-05-28
- Last Posted Date
- 2010-05-07
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00045149
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Biological Therapy in Treating Patients With Metastatic Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-05-26
- Last Posted Date
- 2010-05-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00002786
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia
- Conditions
- T-Cell Prolymphocytic LeukemiaB-Cell Prolymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaChronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma
- Interventions
- Procedure: Hematopoietic Cell TransplantationOther: Laboratory Biomarker AnalysisProcedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationRadiation: Total-Body Irradiation
- First Posted Date
- 2003-05-07
- Last Posted Date
- 2017-12-08
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT00060424
- Locations
- 🇺🇸
Veterans Administration Center-Seattle, Seattle, Washington, United States
🇮🇹University of Torino, Torino, Italy
🇺🇸Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
- Conditions
- Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2010-05-14
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00054340
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Conditions
- Refractory Multiple Myeloma
- Interventions
- Radiation: total-body irradiationProcedure: nonmyeloablative allogeneic hematopoietic stem cell transplantationProcedure: peripheral blood stem cell transplantationOther: laboratory biomarker analysis
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2017-10-16
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT00054353
- Locations
- 🇮🇹
University of Torino, Torino, Italy
🇺🇸Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
- Conditions
- Childhood Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent DiseaseAccelerated Phase of DiseaseChronic Phase of Disease
- Interventions
- Radiation: Total-Body IrradiationProcedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationProcedure: Peripheral Blood Stem Cell TransplantationBiological: Therapeutic Allogeneic LymphocytesOther: Laboratory Biomarker Analysis
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-01-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT00003145
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
🇺🇸Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸Stanford University Hospitals and Clinics, Stanford, California, United States
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer
- Conditions
- Recurrent Renal Cell CancerStage IV Renal Cell Cancer
- Interventions
- Radiation: total-body irradiationProcedure: nonmyeloablative allogeneic hematopoietic stem cell transplantationProcedure: peripheral blood stem cell transplantationBiological: therapeutic allogeneic lymphocytesOther: laboratory biomarker analysis
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 11
- Registration Number
- NCT00005851
- Locations
- 🇺🇸
Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States
🇺🇸Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib
- Conditions
- Recurrent Adult Acute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic PhaseChildhood Acute Lymphoblastic Leukemia in RemissionChildhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent DiseaseAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Chronic Phase of Disease
- Interventions
- Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationProcedure: Peripheral Blood Stem Cell TransplantationBiological: Therapeutic Allogeneic LymphocytesRadiation: Total-Body Irradiation
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-01-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT00036738
- Locations
- 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States
🇺🇸Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States
Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
- Conditions
- Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00002792
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States